跳至主要内容
临床试验/NCT02108587
NCT02108587撤回不适用

Staging of Upper Tract Urothelial Cancer With Optical Coherence Tomography

Case Comprehensive Cancer Center0 个研究点开始时间: 2016年12月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Feasibility of optical coherence tomography (OCT) images in staging upper-tract urothelial carcinomas (UTUC)

研究概览

简要总结

This clinical trial studies how well optical coherence tomography works in staging patients with upper-tract urothelial carcinomas. Staging describes the severity of a person's cancer based on the size and/or extent (reach) of the original (primary) tumor and whether or not cancer has spread in the body. It also helps the doctor plan the appropriate treatment. Optical coherence tomography is a procedure that uses infrared light waves to give three-dimensional pictures of structures inside tissues and organs. The pictures are made by a computer linked to the light source. Optical coherence tomography may be effective in staging patients with upper-tract urothelial carcinomas.

详细描述

PRIMARY OBJECTIVES:

I. To test the feasibility and imaging ability of optical coherence tomography (OCT) to stage upper-tract urothelial carcinomas (UTUC).

OUTLINE:

Patients undergo optical coherence tomography over 10-15 minutes.

After completion of study, patients are followed up at 3 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must have radiographic evidence of upper tract urothelial cancer by computed tomography (CT), magnetic resonance imaging (MRI) or intravenous pyelogram (IVP) in order to undergo this procedure
  • Patient who will undergo standard of care clinical staging for UTUC
  • Patient ability to read and comprehend the informed consent document

排除标准

  • Patient who has a contraindication to endoscopy
  • Patient who is pregnant

结局指标

主要结局

Feasibility of optical coherence tomography (OCT) images in staging upper-tract urothelial carcinomas (UTUC)

时间窗: Up to 3 months

Feasibility defined as the ability to relate the features associated with cancerous tissues in pathohistological analysis to the features in OCT images

次要结局

  • Imaging Analysis(Up to 3 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验